Characterisation of monoclonal antibodies to the TNF and TNF receptor families

被引:13
|
作者
Ch'en, PFT
Xu, XG
Liu, XS
Liu, Y
Song, CJ
Screaton, GR
Jin, BQ [1 ]
Xu, XN
机构
[1] Fourth Mil Med Univ, Dept Immunol, Xian 710032, Peoples R China
[2] John Radcliffe Hosp, MRC, Human Immunol Unit, Weatherall Inst Mol Med, Oxford OX3 9DS, England
[3] Univ London Imperial Coll Sci & Technol, Hammersmith Hosp, London W12 0NN, England
关键词
DcR; decoy receptor; DR; death receptor; TRAIL; TNF related apoptosis inducing ligand; APRIL; a proliferation inducing ligand; BAFF; B cell activating factor of the TNF family; BAFF-R; BAFF receptor; BCMA; B cell maturation antigen; TACI; transmembrane activator and CAM L integrator;
D O I
10.1016/j.cellimm.2005.08.010
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Tumour necrosis factor (TNF) family ligands and their corresponding receptors play important roles in the immune system and are involved in immune regulation such as lymphoid development, cell proliferation, differentiation, activation and death. Antibodies against these ligands and receptors together with Fc-fusion proteins, have been particularly useful as immunological tools in addressing the underlying involvement of these proteins in these contexts and furthermore, have given us hope in using them as potential therapeutic agents. Over last few years, there have been many additions to these ever-growing TNF family ligands and their receptors. Here, we have generated and characterised a set of monoclonal antibodies, together with mAbs from the HLDA workshop, against DcR1, DcR2, DR4, DR5, TRAIL, APRIL, BAFF, BAFF-R, BCMA, and TACI, which may be useful in phenotypic and functional studies of the role of TNF and TNF receptor family in immune function and regulation in relation to health and disease. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:78 / 85
页数:8
相关论文
共 50 条
  • [1] Infectious pulmonary complications in patients treated with anti-TNF-α monoclonal antibodies and soluble TNF receptor
    Carbone J.
    Perez-Rojas J.
    Sarmiento E.
    Current Infectious Disease Reports, 2009, 11 (3) : 229 - 236
  • [2] MONOCLONAL-ANTIBODIES TO SOLUBLE HUMAN TNF RECEPTOR (TNF BINDING-PROTEIN) ENHANCE ITS ABILITY TO BLOCK TNF TOXICITY
    ADOLF, GR
    FRUHBEIS, B
    CYTOKINE, 1992, 4 (03) : 180 - 184
  • [3] INHIBITION OF TNF BY A TNF RECEPTOR IMMUNOADHESIN - COMPARISON TO AN ANTI-TNF MONOCLONAL-ANTIBODY
    HAAKFRENDSCHO, M
    MARSTERS, SA
    MORDENTI, J
    BRADY, S
    GILLETT, NA
    CHEN, SA
    ASHKENAZI, A
    JOURNAL OF IMMUNOLOGY, 1994, 152 (03): : 1347 - 1353
  • [4] Safety of monoclonal antibodies to TNF alpha in the treatment of arthritis
    Fleischmann, Roy
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 8 - 8
  • [5] UNRAVELING FUNCTION IN THE TNF LIGAND AND RECEPTOR FAMILIES
    BEUTLER, B
    VANHUFFEL, C
    SCIENCE, 1994, 264 (5159) : 667 - 668
  • [6] Genomes of diverse organisms tell the tale of the evolution of the TNF/TNF receptor families of proteins
    Duda, E
    Tubak, V
    Ungvári, I
    TISSUE ANTIGENS, 2004, 64 (04): : 342 - 342
  • [7] MONOCLONAL ANTITUMOR NECROSIS FACTOR (TNF) ANTIBODIES PROTECT MOUSE AND HUMAN-CELLS FROM TNF CYTOTOXICITY
    GALLOWAY, CJ
    MADANAT, MS
    MITRA, G
    JOURNAL OF IMMUNOLOGICAL METHODS, 1991, 140 (01) : 37 - 43
  • [8] Variations of TNF and TNF receptor superfamily
    Lee, JK
    Kim, JY
    Ryu, HJ
    Kim, JJ
    Moon, SM
    Oh, B
    Park, C
    Kimm, K
    TISSUE ANTIGENS, 2004, 64 (04): : 392 - 392
  • [9] The TNF-TNF receptor system
    Hehlgans, T
    Männel, DN
    BIOLOGICAL CHEMISTRY, 2002, 383 (10) : 1581 - 1585
  • [10] ABATACEPT AND ANTI-TNF MONOCLONAL ANTIBODIES: EFFICACY AND SAFETY COMPARISONS
    Schiff, M.
    Dougados, M.
    Fleischmann, R.
    Fay, J.
    Maldonado, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 461 - 462